Innovation
1 patent family — focus: Human necessities; filing pace dormant.
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Private equity | 2 | 67% |
Drug delivery technology to improve pharmacokinetics and pharmacodynamics of drugs for Parkinson's, insomnia and ulcers.
1 patent family — focus: Human necessities; filing pace dormant.
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Private equity | 2 | 67% |